Capital Asset Advisory Services’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$4.46M Sell
4,845
-1,081
-18% -$1.1M 0.17% 75
2025
Q4
$6.31M Sell
5,926
-504
-8% -$482K 0.25% 51
2025
Q3
$4.91M Buy
6,430
+315
+5% +$234K 0.21% 63
2025
Q2
$4.74M Buy
6,115
+197
+3% +$153K 0.22% 57
2025
Q1
$4.84M Buy
5,918
+152
+3% +$126K 0.25% 54
2024
Q4
$4.51M Buy
5,766
+531
+10% +$440K 0.22% 60
2024
Q3
$4.78M Buy
5,235
+82
+2% +$73.7K 0.24% 53
2024
Q2
$4.8M Sell
5,153
-365
-7% -$292K 0.26% 49
2024
Q1
$4.33M Buy
5,518
+198
+4% +$141K 0.25% 49
2023
Q4
$3.1M Sell
5,320
-197
-4% -$115K 0.19% 63
2023
Q3
$3.34M Buy
5,517
+267
+5% +$138K 0.23% 54
2023
Q2
$2.36M Buy
5,250
+261
+5% +$109K 0.16% 72
2023
Q1
$1.71M Buy
4,989
+372
+8% +$125K 0.13% 90
2022
Q4
$1.69M Buy
4,617
+824
+22% +$292K 0.14% 85
2022
Q3
$1.23M Buy
3,793
+573
+18% +$182K 0.16% 72
2022
Q2
$1.04M Buy
3,220
+40
+1% +$12K 0.12% 119
2022
Q1
$911K Buy
3,180
+380
+14% +$97.8K 0.1% 161
2021
Q4
$773K Buy
2,800
+90
+3% +$22.8K 0.08% 181
2021
Q3
$626K Hold
2,710
0.07% 214
2021
Q2
$622K Sell
2,710
-188
-6% -$37.8K 0.07% 208
2021
Q1
$541K Sell
2,898
-10
-0.3% -$1.96K 0.08% 234
2020
Q4
$491K Sell
2,908
-10
-0.3% -$1.49K 0.09% 204
2020
Q3
$432K Buy
2,918
+44
+2% +$6.81K 0.09% 187
2020
Q2
$433K Buy
2,874
+99
+4% +$15.2K 0.09% 195
2020
Q1
$438K Sell
2,775
-27
-1% -$3.71K 0.12% 146
2019
Q4
$404K Buy
+2,802
New +$325K 0.09% 208

Other funds holding LLY

Capital Asset Advisory Services's LLY Position: Q1 2026 in Review

Capital Asset Advisory Services reduced its Eli Lilly (LLY) stake by 18% in Q1 2026, selling an estimated $1.1M and leaving 4,845 shares worth $4.46M. The position accounts for 0.17% of the portfolio, ranked #75.

Capital Asset Advisory Services first reported a position in LLY in Q4 2019 and has held it in 26 quarters since. The position peaked at $6.31M in Q4 2025. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Capital Asset Advisory Services held 4,845 shares of Eli Lilly worth $4.46M as of Q1 2026.
  • Capital Asset Advisory Services sold 1,081 Eli Lilly shares in Q1 2026, an estimated $1.1M.
  • Eli Lilly made up 0.17% of Capital Asset Advisory Services's portfolio in Q1 2026, its #75 holding.
  • Capital Asset Advisory Services first reported a position in Eli Lilly in Q4 2019 and has held it in 26 quarters since.
  • Capital Asset Advisory Services's Eli Lilly position peaked at $6.31M in Q4 2025.
  • 4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Capital Asset Advisory Services's 13F filing for Q1 2026, filed 24 Apr 2026.